Audiometry | Ear, Nose & Throat Journal Skip to content Skip to navigation


A controlled comparison of auditory steady-state responses and pure-tone audiometry in patients with hearing loss

November 3, 2017  |  Raman Wadhera, MS; Sharad Hernot, MS; Sat Paul Gulati, MS; Vijay Kalra, MS


We performed a prospective interventional study to evaluate correlations between hearing thresholds determined by pure-tone audiometry (PTA) and auditory steady-state response (ASSR) testing in two types of patients with hearing loss and a control group of persons with normal...

Evaluation of transiently evoked otoacoustic emissions and auditory brainstem responses in patients with multiple sclerosis

October 25, 2016  |  Emre Kaytancı, MD; O. Ilkay Ozdamar, MD; Gul Ozbilen Acar, MD; Muhammet Tekin, MD


Multiple sclerosis (MS) is an inflammatory and demyelinating disease of the central nervous system. This prospective study was planned to evaluate these changes through brainstem evoked response audiometry (BERA) latency abnormalities and otoacoustic emissions (OAE). This study...

Effects on auditory function of chronic exposure to electromagnetic fields from mobile phones

August 21, 2016  |  Sanjeev Bhagat, MS(ENT); Saurabh Varshney, MS(ENT); Sampan Singh Bist, MS(ENT); Deepak Goel, DM(Neurology); Sarita Mishra, MS(ENT); Vivek Kumar Jha, MSLAP


The widespread use of mobile phones has given rise to apprehension regarding the possible hazardous health effects of high-frequency electromagnetic fields (EMFs) on auditory function. We conducted a study to investigate the effects of long-term (>4 yr) exposure to EMFs...

Is there a need for audiologic evaluation in patients with Behçet disease?

March 1, 2012  |  Saniye Cinar, MD, Fikret Cinar, MD, and Sibel Kiran, MD, PhD

Abstract. Behçet disease is known to be a multisystem condition. We conducted a study to determine the prevalence of hearing loss in patients with Behçet disease and to identify any associations between audiologic findings and other clinical manifestations and treatment. Our study group was made...

Middle ear encephalocele: Not just another chronic ear

February 18, 2012  |  John C. Goddard, MD and Jose N. Fayad, MD

The role of ultrahigh-frequency audiometry in the early detection of systemic drug-induced hearing loss

May 1, 2011  |  Rajeev Singh Chauhan, MS, Ravinder Kumar Saxena, MS, and Saurabh Varshey, MS


In monitoring patients for drug-induced hearing loss, most audiometric evaluations are limited to the range of frequencies from 0.25 to 8 kHz. However, such testing would fail to detect ototoxicity in patients who have already experienced hearing loss in the ultrahigh...

The effects of glutathione enhancement on sensorineural hearing loss

September 1, 2010  |  Robert T. Sataloff, MD, DMA, FACS, Therese Bittermann, MD, Linda Marks, RN, Deborah Lurie, PhD, and Mary Hawkshaw, BSN, RN, CORLN


Previous research has demonstrated the benefits of anti-oxidant treatment in the prevention of hearing loss in animals. Our study tested the effects of an undenatured whey protein supplement rich in glutathione on human patients with hearing loss. Over an average of 36 months,...

How to eliminate air-bone gaps audiometrically: Use too much masking

May 1, 2008  |  Maurice H. Miller, PhD


The excessive, indiscriminate use of masking during measurements of pure-tone bone-conduction thresholds can reduce or eliminate air-bone gaps. This may result in an abnormal, audiometrically induced bone-conduction threshold shift and suggest to the otologist the need for...

Audiometry: Masking

October 1, 2006  |  Mohamed A. Hamid, MD, PhD; Kenneth H. Brookler, MD

The 'normal' audiogram

August 1, 2006  |  Kenneth H. Brookler, MD; Mohamed A. Hamid, MD, PhD

Auditory steady-state response audiometry in profound SNHL: The impact of abnormal middle ear function

May 1, 2005  |  Ross Tonini, AuD; Charles Ballay, MD; Spiros Manolidis, MD
Auditory steady-state response (ASSR) audiometry is a commercially available tool that is used to predict... Subscribe to Audiometry